BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 29375208)

  • 1. Hepatitis C virus core protein-induced miR-93-5p up-regulation inhibits interferon signaling pathway by targeting IFNAR1.
    He CL; Liu M; Tan ZX; Hu YJ; Zhang QY; Kuang XM; Kong WL; Mao Q
    World J Gastroenterol; 2018 Jan; 24(2):226-236. PubMed ID: 29375208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathway.
    Mukherjee A; Di Bisceglie AM; Ray RB
    J Virol; 2015 Mar; 89(6):3356-65. PubMed ID: 25589644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Cytomegalovirus miR-US33as-5p Targets IFNAR1 to Achieve Immune Evasion During Both Lytic and Latent Infection.
    Zhang Q; Song X; Ma P; Lv L; Zhang Y; Deng J; Zhang Y
    Front Immunol; 2021; 12():628364. PubMed ID: 33746965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of STAT Pathway Impairs Anti-Hepatitis C Virus Effect of Interferon Alpha.
    Zhao LJ; He SF; Liu Y; Zhao P; Bian ZQ; Qi ZT
    Cell Physiol Biochem; 2016; 40(1-2):77-90. PubMed ID: 27855377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chaperone-Mediated Autophagy Targets IFNAR1 for Lysosomal Degradation in Free Fatty Acid Treated HCV Cell Culture.
    Kurt R; Chandra PK; Aboulnasr F; Panigrahi R; Ferraris P; Aydin Y; Reiss K; Wu T; Balart LA; Dash S
    PLoS One; 2015; 10(5):e0125962. PubMed ID: 25961570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFN-λ Inhibits MiR-122 Transcription through a Stat3-HNF4α Inflammatory Feedback Loop in an IFN-α Resistant HCV Cell Culture System.
    Aboulnasr F; Hazari S; Nayak S; Chandra PK; Panigrahi R; Ferraris P; Chava S; Kurt R; Song K; Dash A; Balart LA; Garry RF; Wu T; Dash S
    PLoS One; 2015; 10(12):e0141655. PubMed ID: 26657215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the nonstructural protein 4B of hepatitis C virus as a factor that inhibits the antiviral activity of interferon-alpha.
    Xu J; Liu S; Xu Y; Tien P; Gao G
    Virus Res; 2009 Apr; 141(1):55-62. PubMed ID: 19185598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of microRNA-199a-5p reduces the replication of HCV via regulating the pro-survival pathway.
    Wang H; Gao H; Duan S; Song X
    Virus Res; 2015 Oct; 208():7-12. PubMed ID: 26027911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-Regulation of ID2-AS1 Alleviates the Neuronal Injury Induced by 1-Methy1-4-Phenylpyridinium in Human Neuroblastoma Cell Line SH-SY5Y Cells Through Regulating miR-199a-5p/IFNAR1/JAK2/STAT1 Axis.
    Xu F; Wang H; Tian J; Xu H
    Neurochem Res; 2021 Aug; 46(8):2192-2203. PubMed ID: 34050453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (-)-Epigallocatechin-3-gallate enhances poly I:C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes.
    Wang YZ; Li JL; Wang X; Zhang T; Ho WZ
    World J Gastroenterol; 2017 Aug; 23(32):5895-5903. PubMed ID: 28932081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribavirin enhances IFN-α signalling and MxA expression: a novel immune modulation mechanism during treatment of HCV.
    Stevenson NJ; Murphy AG; Bourke NM; Keogh CA; Hegarty JE; O'Farrelly C
    PLoS One; 2011; 6(11):e27866. PubMed ID: 22114715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients.
    Liu B; Chen S; Guan Y; Chen L
    PLoS One; 2015; 10(7):e0133800. PubMed ID: 26193702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus non-structural 5A abrogates signal transducer and activator of transcription-1 nuclear translocation induced by IFN-alpha through dephosphorylation.
    Gong GZ; Cao J; Jiang YF; Zhou Y; Liu B
    World J Gastroenterol; 2007 Aug; 13(30):4080-4. PubMed ID: 17696225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the STAT1‑interacting domain of the hepatitis C virus core protein modulate the response to antiviral therapy.
    Anjum S; Afzal MS; Ahmad T; Aslam B; Waheed Y; Shafi T; Qadri I
    Mol Med Rep; 2013 Aug; 8(2):487-92. PubMed ID: 23799612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon alpha decreases expression of human scavenger receptor class BI, a possible HCV receptor in hepatocytes.
    Murao K; Imachi H; Yu X; Cao WM; Nishiuchi T; Chen K; Li J; Ahmed RA; Wong NC; Ishida T
    Gut; 2008 May; 57(5):664-71. PubMed ID: 17998316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus core protein modulates the interferon-induced transacting factors of Jak/Stat signaling pathway but does not affect the activation of downstream IRF-1 or 561 gene.
    Basu A; Meyer K; Ray RB; Ray R
    Virology; 2001 Sep; 288(2):379-90. PubMed ID: 11601909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix Metalloproteinase 9 Facilitates Hepatitis B Virus Replication through Binding with Type I Interferon (IFN) Receptor 1 To Repress IFN/JAK/STAT Signaling.
    Chen J; Xu W; Chen Y; Xie X; Zhang Y; Ma C; Yang Q; Han Y; Zhu C; Xiong Y; Wu K; Liu F; Liu Y; Wu J
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28122987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the oncogenic miR-21-5p promotes HCV replication and steatosis induced by the viral core 3a protein.
    Clément S; Sobolewski C; Gomes D; Rojas A; Goossens N; Conzelmann S; Calo N; Negro F; Foti M
    Liver Int; 2019 Jul; 39(7):1226-1236. PubMed ID: 30938910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR146a impairs the IFN-induced anti-HBV immune response by downregulating STAT1 in hepatocytes.
    Hou ZH; Han QJ; Zhang C; Tian ZG; Zhang J
    Liver Int; 2014 Jan; 34(1):58-68. PubMed ID: 23890093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-185-5p mediates regulation of SREBP2 expression by hepatitis C virus core protein.
    Li M; Wang Q; Liu SA; Zhang JQ; Ju W; Quan M; Feng SH; Dong JL; Gao P; Cheng J
    World J Gastroenterol; 2015 Apr; 21(15):4517-25. PubMed ID: 25914460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.